Physician profile
David J Nicholson
NPI 1083779466
$27,811.47
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $311 · 2021: $144 · 2022: $805 · 2023: $8,509 · 2024: $4,857 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $2,487 · Consulting Fee: $1,590 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,000.00 |
| Food and Beverage | $2,487.14 |
| Consulting Fee | $1,590.00 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,833.25 | 2020-2025 | Watchman Access System, Watchman, Watchman Flx |
| Edwards Lifesciences Corporation | $2,348.88 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Heartflow, INC. | $621.88 | 2022-2025 | |
| Medtronic, INC. | $560.46 | 2022-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $362.10 | 2020-2025 | Mitraclip, Amplatzer Amulet |
| Medtronic Vascular, INC. | $231.93 | 2019-2020 | |
| Novo Nordisk INC | $206.14 | 2023-2025 | Ozempic, Wegovy |
| Amgen INC. | $122.81 | 2022-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.56 | 2019-2024 | Lifevest |
| Allergan, INC. | $97.33 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $60.78 | 2022-2025 | Farxiga |
| Sanofi-Aventis U.S. LLC | $46.18 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $37.35 | 2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $33.05 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $29.52 | 2022-2023 | Xarelto |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $26.35 | 2024 | (6571) Eagle Eye |
| Cardiva Medical, INC. | $21.22 | 2024 | Savvywire |
| Teleflex LLC | $20.47 | 2023 | Guideliner |
| Ironshore Pharmaceuticals INC. | $18.86 | 2022 | |
| Esperion Therapeutics, INC. | $16.28 | 2024 | Nexletol |
| Coopersurgical, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.